Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP-CAT Study
NCT03102515Phase 4Completed
- Sponsor
- CHU Caen Normandie
- Start
- May 2016
- Primary completion
- Oct 2016
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
01
Overview
Phase 4, randomised trial of COVID-19-Influenza Combination vaccine in postoperative pain (2 arms), sponsored by CHU Caen Normandie. Primary endpoint: Postoperative standing pain at day 2. Started May 2016; status: completed.
02
Drugs
COVID-19-Influenza Combination vaccine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03102515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03102515.